Login
$HAE
$121.34 +$0.00 (0.0%) After hours

$HAE SEC Filings

Filed On Filing
13 Nov 2026 Form 4: Maunsell Farris Maryanne, VP, Chief Accounting Officer

Received 2,146 shares by exercise or conversion ($187K) · Gave up 1,724 shares to cover exercise price or tax ($209K) · Sold 836 shares ($101K)

12 Nov 2026 144
05 Nov 2026 10-Q
05 Nov 2026 8-K: Results of Operations and Financial Condition

Boston, MA, November 5, 2026 - Haemonetics Corporation (NYSE: HAE) reported financial results for its second quarter of fiscal 2027, which ended September 26, 2026:

03 Nov 2026 Form 4: Galvin Roy, EVP, Chief Commercial Officer

Gave up 146 shares to cover exercise price or tax ($17.5K)

08 Oct 2026 8-K: Regulation FD Disclosure

On August 18, 2026, Haemonetics Corporation (the “Company”) furnished a Current Report on Form 8-K disclosing its entry into a non-exclusive supply agreement with CSL Plasma Inc. (“CSL”), under which CSL may utilize the Company’s NexSys ...

18 Aug 2026 8-K: Regulation FD Disclosure

On August 14, 2026, Haemonetics Corporation (the “Company”) entered into a supply agreement with CSL Plasma Inc. (“CSL”) pursuant to which CSL may utilize the Company’s NexSys PCS® devices with Persona® PLUS technology and purchase relat...

12 Aug 2026 SCHEDULE 13G/A
06 Aug 2026 S-8
06 Aug 2026 10-Q
06 Aug 2026 8-K: Results of Operations and Financial Condition

Boston, MA, August 6, 2026 - Haemonetics Corporation (NYSE: HAE) reported financial results for its first quarter of fiscal 2027, which ended June 27, 2026:

28 Jul 2026 Form 4: Madaus Martin D, Director

Received 2,538 shares as a grant or award

28 Jul 2026 Form 4: Zane Ellen M, Director

Received 2,538 shares as a grant or award

28 Jul 2026 Form 4: Pomeroy Claire, Director

Received 2,538 shares as a grant or award

28 Jul 2026 Form 4: Kroll Mark W, Director

Received 2,538 shares as a grant or award

28 Jul 2026 Form 4: Johnson Lloyd Emerson, Director

Received 2,538 shares as a grant or award

28 Jul 2026 Form 4: Coyle Michael J, Director

Received 2,538 shares as a grant or award

28 Jul 2026 Form 4: Bryant Diane M, Director

Received 2,538 shares as a grant or award

28 Jul 2026 Form 4: Abernathy Robert E, Director

Received 2,538 shares as a grant or award

28 Jul 2026 Form 3: Madaus Martin D, Director

No securities owned

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support